Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
The ability to predict recurrence and survival after neoadjuvant chemotherapy (NAC) and surgery for oesophageal cancer remains elusive. This study evaluated the role of [18F]fluorodeoxyglucose (FDG) PET–CT in assessing tumour and nodal response as a prognostic marker.
This was a single-centre UK cohort study. From 2006 to 2014, patients with oesophageal cancer staged with PET–CT before NAC, and restaged by CT or PET–CT before resection, were inc...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher copy:
- Pubs id:
- Local pid:
- Deposit date:
- Copyright date:
If you are the owner of this record, you can report an update to it here: Report update to this record